Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4397436 | 0.77 | NOS2 (0.36) | — | |
| SCHEMBL16479463 | 0.73 | CA1 (0.39) | ALDH1A1LMNAHTTGAACA2 | |
| SCHEMBL4396824 | 0.69 | ALDH1A1 (0.55) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL4391340 | 0.67 | KDM4E (0.39) | GAACA2 | |
| SCHEMBL31287327 | 0.64 | CA1 (0.33) | CA2CA1XDH | |
| SCHEMBL31419445 | 0.64 | CA1 (0.33) | LMNACA2CA1XDH | |
| SCHEMBL3365956 | 0.64 | ALDH1A1 (0.44) | ALDH1A1LMNATSHRHTTGAA | |
| SCHEMBL24184679 | 0.63 | LMNA (0.34) | ALDH1A1LMNACA2CA1HSD17B10 | |
| SCHEMBL2521310 | 0.63 | CA1 (0.40) | ALDH1A1LMNACA2CA1 | |
| SCHEMBL7648217 | 0.62 | ALDH1A1 (0.38) | ALDH1A1TSHRHTTGAACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | ALDH1A1 27/4885LMNA 2570/4885TSHR 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.